LDR brachytherapy of "low risk" prostate cancer: Update of the 5-year experience in 118 patients

被引：0
作者：
Block, T.
Zimmermann, F.
Czempiel, H.
机构：
[1] Urol Praxis, Vaterstetten, Germany
[2] Tech Univ Munich, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2007年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
[41]   HDR BRACHYTHERAPY FOR PROSTATE CANCER: 5 YEARS EXPERIENCE [J].
Palmieri, L. ;
Sacco, S. ;
Frigerio, C. ;
Sangalli, G. ;
Declich, F. ;
Colombo, A. .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 :S36-S36
[42]   Early results of LDR brachytherapy 108 Gy and ultrahypofractionated 5*5 Gy SBRT for prostate cancer [J].
Zimmermann, Joerg S. ;
Wuerschmidt, Florian ;
Munzert, Sebastian ;
Eckert, Carl Christian ;
Nicolay, Nils Henrik ;
Moustakis, Christos .
RADIOTHERAPY AND ONCOLOGY, 2024, 194 :S406-S408
[43]   Does a delay in low dose rate (LDR) brachytherapy after tissue diagnosis affect outcome for men with low risk prostate cancer? [J].
Andrews, SF ;
Horwitz, EM ;
Feigenberg, SJ ;
Eisenberg, DF ;
Uzzo, RG ;
Pollack, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02) :S323-S323
[44]   8-year observation results in n=1023 patients with low, intermediate and high risk prostate cancer after I-125 LDR brachytherapy ± EBRT ± antihormonal treatment [J].
Zimmermann, J. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 :41-42
[45]   Gabapentin in the Treatment of Hiccups in Patients With Advanced Cancer: A 5-Year Experience [J].
Porzio, Giampiero ;
Aielli, Federica ;
Verna, Lucilla ;
Aloisi, Paolo ;
Galletti, Brigida ;
Ficorella, Corrado .
CLINICAL NEUROPHARMACOLOGY, 2010, 33 (04) :179-180
[46]   CANCER OF THE ESOPHAGUS 5-YEAR LOCAL EXPERIENCE [J].
OCONNOR, TM ;
WATSON, RR ;
WEISEL, W .
WISCONSIN MEDICAL JOURNAL, 1980, 79 (02) :35-39
[47]   Prostate-specific antigen (PSA) kinetics following focal low-dose-rate (LDR) brachytherapy for intermediate risk prostate cancer [J].
Harkin, Timothy ;
Smyth, Lloyd ;
Anderson, Elliot ;
O'Sullivan, Richard ;
Ryan, Andrew ;
Lawrentschuk, Nathan ;
Katz, Darren ;
Grummet, Jeremy ;
See, Andrew .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 :91-91
[48]   PREDICTING THE RISK OF 5-YEAR BIOCHEMICAL RECURRENCE IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER: THE PIPEN RISK CATEGORIES [J].
Luzzago, Stefano ;
Mistretta, Francesco Alessandro ;
Ferro, Matteo ;
Piccinelli, Mattia Luca ;
Di Trapani, Ettore ;
Cordima, Giovanni ;
Bottero, Danilo ;
Santangelo, Emanuela ;
Zago, Agnese ;
Nardini, Sara ;
Caramella, Stefano ;
Vaccaro, Chiara ;
Marvaso, Giulia ;
Jereczek-Fossa, Barbara Alicja ;
Musi, Gennaro ;
De Cobelli, Ottavio .
ANTICANCER RESEARCH, 2023, 43 (10) :4757-4757
[49]   High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort [J].
Marotte, Delphine ;
Gal, Jocelyn ;
Schiappa, Renaud ;
Gautier, Mathieu ;
Boulahssass, Rabia ;
Chand-Fouche, Marie-Eve ;
Hannoun-Levi, Jean-Michel .
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 35 :104-109
[50]   Population outcomes of EBRT with LDR brachytherapy boost for intermediate, high-risk prostate cancer [J].
Oh, J. ;
Spadinger, I. ;
Lapointe, V. ;
Morris, J. .
RADIOTHERAPY AND ONCOLOGY, 2020, 152 :S372-S372
12345